While Peng et al. reported higher overall SARS-CoV-2-specific T cell responses in severe cases compared to patients with mild COVID-19, in patients with mild disease, a larger proportion of the T cell responses to spike protein and M and N were contributed by CD8+ T cells compared with those patients with severe COVID-19 [35]. This evidence concerns the gene CD8A and COVID-19.